【摘要】 目的　研究复美新滴眼液在玻璃体视网膜手术中抑制瞳孔缩小的作用。方法　对照组术前使用阿托品和复方托吡卡胺滴眼液散瞳 ,实验组加用复美新滴眼液 ,比较两组的区别。结果　实验组平均瞳孔缩小 0 2 5mm ,明显小于对照组缩小值 1 3 1mm (P <0 0 1)。根据手术方法不同将患者分为 3组比较 ,手术结束时平均瞳孔缩小值实验组均小于对照组 (P <0 0 1)。实验组中增生型糖尿病视网膜病变患者手术结束时平均瞳孔缩小值为 0 5mm ,明显小于对照组中糖尿病患者平均缩小值 1 5mm (P <0 0 1)。根据手术时间不同比较 ,实验组瞳孔缩小值均小于对照组 (P <0 0 1)。结论　复美新可有效抑制玻璃体视网膜手术中瞳孔缩小 ,尤其对于时间较长的复杂手术效果更显著。更多还原

【Abstract】 ObjectiveTo evaluate the inhibition of voltamicin eyedrops on miosis during vitreoretinal surgery.MethodsAtropine eyedrops and tropicamide/phenylephrine eyedrops were used preoperatively in control group.Voltamicin was added to the trial group except for using atropine eyedrops and tropicamide/phenylephrine eyedrops.Pupil size was measured before and immediately after surgery.ResultsThe mean decreasing value of pupil diameter in votamicin group and control group was 0.25 mm and 1.31 mm,respectively,showing a statistical significance(P<0.05).The mean decreasing value in pupil diameter in votamicin group was less than that of control group for various operative types(P<0.01).The mean decrease of pupil size for the patients with proliferative diabetic retinopathy was 0.5 mm in votamicin group,but 1.5 mm in control group(P<0.05).The mean decrease of pupil size in votamicin group was also less than that of control group for different operation time(P<0.01).ConclusionVotamicin is an effective eyedrops for inhibiting miosis during vitreoretinal surgery,especially for complicated and prolonged surgery.更多还原